Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,781,663
in 3 filings, $2.8M under 10b5-1 plans

Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-09 Daniel Jennifer SVP & Chief HR Officer Exercise or conversion · Stock Option (right to buy) −2,006 34,113
2021-02-08 Daniel Jennifer SVP & Chief HR Officer Exercise or conversion +2,006 $17.00 $34K 8,694
2021-02-08 Daniel Jennifer SVP & Chief HR Officer Sale −2,006 $100.00 $201K 6,688
2021-02-08 Daniel Jennifer SVP & Chief HR Officer Exercise or conversion · Stock Option (right to buy) −2,006 36,119
2021-02-05 Lebowitz Joel Sale −1,115 $99.90 $111K 0
2021-02-05 Daniel Jennifer SVP & Chief HR Officer Exercise or conversion +2,006 $17.00 $34K 8,694
2021-02-05 Daniel Jennifer SVP & Chief HR Officer Sale −2,006 $99.80 $200K 6,688
2021-02-05 Daniel Jennifer SVP & Chief HR Officer Exercise or conversion · Stock Option (right to buy) −2,006 38,125
2021-02-05 Abel Robert Lorne EVP, Science Exercise or conversion +4,992 $2.92 $15K 4,992
2021-02-05 Abel Robert Lorne EVP, Science Exercise or conversion +10,881 $1.57 $17K 15,873
2021-02-05 Abel Robert Lorne EVP, Science Sale −3,108 $97.73 $304K 12,765
2021-02-05 Abel Robert Lorne EVP, Science Sale −5,078 $99.05 $503K 7,687
2021-02-05 Abel Robert Lorne EVP, Science Sale −7,687 $99.75 $767K 0
2021-02-05 Abel Robert Lorne EVP, Science Exercise or conversion · Stock Option (right to buy) −4,992 2,214
2021-02-05 Abel Robert Lorne EVP, Science Exercise or conversion · Stock Option (right to buy) −10,881 2,496
2021-02-05 Lebowitz Joel EVP & CFO Exercise or conversion +12,374 $17.00 $210K 12,374
2021-02-05 Lebowitz Joel EVP & CFO Sale −900 $97.90 $88K 11,474
2021-02-05 Lebowitz Joel EVP & CFO Sale −10,359 $99.18 $1.0M 1,115
2021-02-05 Lebowitz Joel EVP & CFO Purchase −1,115 $99.90 $111K 0
2021-02-05 Lebowitz Joel EVP & CFO Exercise or conversion · Stock Option (right to buy) −12,374 37,122

Page 40 of 60 · 1,192 trades